Antimicrobial stewardship: A matter of process or outcome?

Pharmacotherapy

Volumn 32, Issue 8, 2012, Pages 688-706

  Khadem, Tina M ^a   Ashley, Elizabeth Dodds ^a,b   Wrobel, Mark J ^a,c,d   Brown, Jack ^a,c,d  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^c School of Pharmacy and Pharmaceutical Sciences Buffalo   (United States)

^d UNIVERSITY AT BUFFALO   (United States)

Author keywords

Antimicrobial stewardship; Measures; Outcome; Process

Indexed keywords

AMINOGLYCOSIDE; CIPROFLOXACIN;

ANTIMICROBIAL STEWARDSHIP; ANTIMICROBIAL THERAPY; BACTERIAL INFECTION; CLINICAL EFFECTIVENESS; CLINICAL PRACTICE; CLOSTRIDIUM DIFFICILE INFECTION; COST CONTROL; DECISION SUPPORT SYSTEM; DRUG CONTROL; DRUG COST; DRUG USE; EDUCATION PROGRAM; HEALTH CARE QUALITY; HEALTH PROGRAM; HUMAN; MEDICAL CARE; NEPHROTOXICITY; OUTCOME ASSESSMENT; PATIENT EDUCATION; PRACTICE GUIDELINE; PRESCRIPTION; REVIEW; SYSTEMATIC REVIEW; TREATMENT OUTCOME; VENTILATOR ASSOCIATED PNEUMONIA;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; OUTCOME ASSESSMENT (HEALTH CARE); PROCESS ASSESSMENT (HEALTH CARE); QUALITY OF HEALTH CARE; RESEARCH DESIGN;

EID: 84864606296     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.1875-9114.2012.01154.x     Document Type: Review

References (75)

1. National Nosocomial Infections Surveillance (NNIS). System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 2004;32(8):470-85.
2. Boucher HW, Talbot GH, Bradley JS, et al. Bad bugs, no drugs: No ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis 2009;48(1):1-12.
3. Dellit TH, Owens RC, McGowan JE Jr, et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 2007;44(2):159-77.
4. Bal AM, Gould IM. Antibiotic stewardship: Overcoming implementation barriers. Curr Opin Infect Dis 2011;24(4):357-62.
5. Drew RH, White R, MacDougall C, Hermsen ED, Owens RC Jr. Insights from the Society of Infectious Diseases Pharmacists on antimicrobial stewardship guidelines from the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Pharmacotherapy 2009;29(5):593-607.
6. Tamma PD, Cosgrove SE. Antimicrobial stewardship. Infect Dis Clin North Am 2011;25(1):245-60.
7. Harrington HJ, Hoffherr GD, Reid RP. Area activity analysis: Aligning work activities and measurements to enhance business performance. New York, NY: McGraw-Hill, 1999.
8. de Champs C, Franchineau P, Gourgand JM, Loriette Y, Gaulme J, Sirot J. Clinical and bacteriological survey after change in aminoglycoside treatment to control an epidemic of Enterobacter cloacae. J Hosp Infect 1994;28(3):219-29.
9. Climo MW, Israel DS, Wong ES, Williams D, Coudron P, Markowitz SM. Hospital-wide restriction of clindamycin: Effect on the incidence of Clostridium difficile-associated diarrhea and cost. Ann Intern Med 1998;128(12 Pt 1):989-95.
10. Rahal JJ, Urban C, Horn D, et al. Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella. JAMA 1998;280(14):1233-7.
11. Gums JG, Yancey RW Jr, Hamilton CA, Kubilis PS. A randomized, prospective study measuring outcomes after antibi-otic therapy intervention by a multidisciplinary consult team. Pharmacotherapy 1999;19(12):1369-77.
12. Landman D, Chockalingam M, Quale JM. Reduction in the incidence of methicillin-resistant Staphylococcus aureus and ceftazidime-resistant Klebsiella pneumoniae following changes in a hospital antibiotic formulary. Clin Infect Dis 1999;28 (5):1062-6.
13. Raymond DP, Pelletier SJ, Crabtree TD, et al. Impact of a rotating empiric antibiotic schedule on infectious mortality in an intensive care unit. Crit Care Med 2001;29(6):1101-8.
14. Khan R, Cheesbrough J. Impact of changes in antibiotic policy on Clostridium difficile-associated diarrhoea (CDAD) over a five-year period in a district general hospital. J Hosp Infect 2003;54(2):104-8.
15. Valiquette L, Cossette B, Garant MP, Diab H, Pepin J. Impact of a reduction in the use of high-risk antibiotics on the course of an epidemic of Clostridium difficile-associated disease caused by the hypervirulent NAP1/027 strain. Clin Infect Dis 2007;45 (suppl 2):S112-21.
16. Yong MK, Buising KL, Cheng AC, Thursky KA. Improved susceptibility of Gram-negative bacteria in an intensive care unit following implementation of a computerized antibiotic decision support system. J Antimicrob Chemother 2010;65 (5):1062-9.
17. Woodward RS, Medoff G, Smith MD, Gray JL 3rd. Antibiotic cost savings from formulary restrictions and physician monitoring in a medical-school- affiliated hospital. Am J Med 1987;83(5):817-23.
18. Fraser GL, Stogsdill P, Dickens JD Jr, Wennberg DE, Smith RP Jr, Prato BS. Antibiotic optimization. An evaluation of patient safety and economic outcomes. Arch Intern Med 1997;157(15):1689-94.
19. Singh N, Rogers P, Atwood CW, Wagener MM, Yu VL. Shortcourse empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription. Am J Respir Crit Care Med 2000;162(2 Pt 1):505-11.
20. Solomon DH, Van Houten L, Glynn RJ, et al. Academic detailing to improve use of broad-spectrum antibiotics at an academic medical center. Arch Intern Med 2001;161(15):1897 -902.
21. Carling P, Fung T, Killion A, Terrin N, Barza M. Favorable impact of a multidisciplinary antibiotic management program conducted during 7 years. Infect Control Hosp Epidemiol 2003;24(9):699-706.
22. Saizy-Callaert S, Causse R, Furhman C, Le Paih MF, Thebault A, Chouaid C. Impact of a multidisciplinary approach to the control of antibiotic prescription in a general hospital. J Hosp Infect 2003;53(3):177-82.
23. Lautenbach E, LaRosa LA, Marr AM, Nachamkin I, Bilker WB, Fishman NO. Changes in the prevalence of vancomycinresistant enterococci in response to antimicrobial formulary interventions: Impact of progressive restrictions on use of vancomycin and third-generation cephalosporins. Clin Infect Dis 2003;36(4):440-6.
24. Bantar C, Sartori B, Vesco E, et al. A hospitalwide intervention program to optimize the quality of antibiotic use: Impact on prescribing practice, antibiotic consumption, cost savings, and bacterial resistance. Clin Infect Dis 2003;37(2):180-6.
25. Geissler A, Gerbeaux P, Granier I, Blanc P, Facon K, Durand- Gasselin J. Rational use of antibiotics in the intensive care unit: Impact on microbial resistance and costs. Intensive Care Med 2003;29(1):49-54.
26. Ruttimann S, Keck B, Hartmeier C, Maetzel A, Bucher HC. Long-term antibiotic cost savings from a comprehensive intervention program in a medical department of a university- affiliated teaching hospital. Clin Infect Dis 2004;38 (3):348-56.
27. Martin C, Ofotokun I, Rapp R, et al. Results of an antimicrobial control program at a university hospital. Am J Health Syst Pharm 2005;62(7):732-8.
28. Cook PP, Catrou P, Gooch M, Holbert D. Effect of reduction in ciprofloxacin use on prevalence of meticillin-resistant Staphylococcus aureus rates within individual units of a tertiary care hospital. J Hosp Infect 2006;64(4):348-51.
29. Thursky KA, Buising KL, Bak N, et al. Reduction of broadspectrum antibiotic use with computerized decision support in an intensive care unit. Int J Qual Health Care 2006;18(3):224-31.
30. Apisarnthanarak A, Danchaivijitr S, Khawcharoenporn T, et al. Effectiveness of education and an antibiotic-control program in a tertiary care hospital in Thailand. Clin Infect Dis 2006;42(6):768-75.
31. Philmon C, Smith T, Williamson S, Goodman E. Controlling use of antimicrobials in a community teaching hospital. Infect Control Hosp Epidemiol 2006;27(3):239-44.
32. McGregor JC, Weekes E, Forrest GN, et al. Impact of a computerized clinical decision support system on reducing inappropriate antimicrobial use: A randomized controlled trial. J Am Med Inform Assoc 2006;13(4):378-84.
33. Fowler S, Webber A, Cooper BS, et al. Successful use of feedback to improve antibiotic prescribing and reduce Clostridium difficile infection: A controlled interrupted time series. J Antimicrob Chemother 2007;59(5):990-5.
34. Meyer E, Buttler J, Schneider C, et al. Modified guidelines impact on antibiotic use and costs: Duration of treatment for pneumonia in a neurosurgical ICU is reduced. J Antimicrob Chemother 2007;59(6):1148-54.
35. Dellit TH, Chan JD, Skerrett SJ, Nathens AB. Development of a guideline for the management of ventilator-associated pneumonia based on local microbiologic findings and impact of the guideline on antimicrobial use practices. Infect Control Hosp Epidemiol 2008;29(6):525-33.
36. Buising KL, Thursky KA, Robertson MB, et al. Electronic antibiotic stewardship-reduced consumption of broad-spectrum antibiotics using a computerized antimicrobial approval system in a hospital setting. J Antimicrob Chemother 2008;62 (3):608-16.
37. Camins BC, King MD, Wells JB, et al. Impact of an antimicrobial utilization program on antimicrobial use at a large teaching hospital: A randomized controlled trial. Infect Control Hosp Epidemiol 2009;30(10):931-8.
38. Bauer KA, West JE, Balada-Llasat JM, Pancholi P, Stevenson KB, Goff DA. An antimicrobial stewardship program's impact with rapid polymerase chain reaction methicillin-resistant Staphylococcus aureus/S. aureus blood culture test in patients with S. aureus bacteremia. Clin Infect Dis 2010;51(9):1074-80.
39. Toth NR, Chambers RM, Davis SL. Implementation of a care bundle for antimicrobial stewardship. Am J Health Syst Pharm 2010;67(9):746-9.
40. Slain D, Sarwari AR, Petros KO, et al. Impact of a multimodal antimicrobial stewardship program on Pseudomonas aeruginosa susceptibility and antimicrobial use in the intensive care unit setting. Crit Care Res Pract 2011;2011:416426.
41. Di Pentima MC, Chan S, Hossain J. Benefits of a pediatric antimicrobial stewardship program at a children's hospital. Pediatrics 2011;128(6):1062-70.
42. Talpaert MJ, Gopal Rao G, Cooper BS, Wade P. Impact of guidelines and enhanced antibiotic stewardship on reducing broad-spectrum antibiotic usage and its effect on incidence of Clostridium difficile infection. J Antimicrob Chemother 2011;66(9):2168-74.
43. Donabedian A. Evaluating the quality of medical care. 1966. Milbank Q 2005;83(4):691-729.
44. McGowan JE Jr, Finland M. Effects of monitoring the usage of antibiotics: An interhospital comparison. South Med J 1976;69 (2):193-5.
45. Avorn J, Soumerai SB, Taylor W, Wessels MR, Janousek J, Weiner M. Reduction of incorrect antibiotic dosing through a structured educational order form. Arch Intern Med 1988;148 (8):1720-4.
46. Trenholme GM, Kaplan RL, Karakusis PH, et al. Clinical impact of rapid identification and susceptibility testing of bacterial blood culture isolates. J Clin Microbiol 1989;27(6):1342-5.
47. Everitt DE, Soumerai SB, Avorn J, Klapholz H, Wessels M. Changing surgical antimicrobial prophylaxis practices through education targeted at senior department leaders. Infect Control Hosp Epidemiol 1990;11(11):578-83.
48. Shojania KG, Yokoe D, Platt R, Fiskio J, Ma'luf N, Bates DW. Reducing vancomycin use utilizing a computer guideline: Results of a randomized controlled trial. J Am Med Inform Assoc 1998;5(6):554-62.
49. Dranitsaris G, Spizzirri D, Pitre M, McGeer A. A randomized trial to measure the optimal role of the pharmacist in promoting evidence-based antibiotic use in acute care hospitals. Int J Technol Assess Health Care 2001;17(2):171-80.
50. Richards MJ, Robertson MB, Dartnell JG, et al. Impact of a web-based antimicrobial approval system on broad-spectrum cephalosporin use at a teaching hospital. Med J Aust 2003;178 (8):386-90.
51. Ansari F, Gray K, Nathwani D, et al. Outcomes of an intervention to improve hospital antibiotic prescribing: Interrupted time series with segmented regression analysis. J Antimicrob Chemother 2003;52(5):842-8.
52. Agwu AL, Lee CK, Jain SK, et al. A World Wide Web-based antimicrobial stewardship program improves efficiency, communication, and user satisfaction and reduces cost in a tertiary care pediatric medical center. Clin Infect Dis 2008;47(6):747-53.
53. Mant J. Process versus outcome indicators in the assessment of quality of health care. Int J Qual Health Care 2001;13 (6):475-80.
54. Jacob JT, Gaynes RP. Emerging trends in antibiotic use in US hospitals: Quality, quantification and stewardship. Expert Rev Anti Infect Ther 2010;8(8):893-902.
55. Bratzler DW, Hunt DR. The surgical infection prevention and surgical care improvement projects: National initiatives to improve outcomes for patients having surgery. Clin Infect Dis 2006;43(3):322-30.
56. Kumar A, Roberts D, Wood KE, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006;34(6):1589-96.
57. Morrell M, Fraser VJ, Kollef MH. Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: A potential risk factor for hospital mortality. Antimicrob Agents Chemother 2005;49(9):3640-5.
58. Mortensen EM, Restrepo MI, Anzueto A, Pugh JA. Antibiotic therapy and 48-hour mortality for patients with pneumonia. Am J Med 2006;119(10):859-64.
59. Gaieski DF, Mikkelsen ME, Band RA, et al. Impact of time to antibiotics on survival in patients with severe sepsis or septic shock in whom early goal-directed therapy was initiated in the emergency department. Crit Care Med 2010;38(4):1045-53.
60. CMS. Process of care measures. Available from http:// www.cms.gov/Medicare/Quality-Initiatives-Patient-Assessment- Instruments/HospitalQualityInits/HospitalProcessOfCareMeasures. html. Accessed June 16, 2012.
61. Meehan TP, Fine MJ, Krumholz HM, et al. Quality of care, process, and outcomes in elderly patients with pneumonia. JAMA 1997;278(23):2080-4.
62. Houck PM, Bratzler DW, Nsa W, Ma A, Bartlett JG. Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia. Arch Intern Med 2004;164(6):637-44.
63. Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of communityacquired pneumonia in adults. Clin Infect Dis 2007;44(suppl 2):S27-72.
64. The Joint Commission. Pneumonia measures. Available from http://www.jointcommission.org/pneumonia/. Accessed June 16, 2012.
65. Roberts RR, Hota B, Ahmad I, et al. Hospital and societal costs of antimicrobial-resistant infections in a Chicago teaching hospital: Implications for antibiotic stewardship. Clin Infect Dis 2009;49(8):1175-84.
66. Stevens V, Dumyati G, Fine LS, Fisher SG, van Wijngaarden E. Cumulative antibiotic exposures over time and the risk of Clostridium difficile infection. Clin Infect Dis 2011;53 (1):42-8.
67. MacDougall C, Polk RE. Antimicrobial stewardship programs in health care systems. Clin Microbiol Rev 2005;18(4):638-56.
68. Patel D, Lawson W, Guglielmo BJ. Antimicrobial stewardship programs: Interventions and associated outcomes. Expert Rev Anti Infect Ther 2008;6(2):209-22.
69. Bruno-Murtha LA, Brusch J, Bor D, Li W, Zucker D. A pilot study of antibiotic cycling in the community hospital setting. Infect Control Hosp Epidemiol 2005;26(1):81-7.
70. Zahar JR, Rioux C, Girou E, et al. Inappropriate prescribing of aminoglycosides: Risk factors and impact of an antibiotic control team. J Antimicrob Chemother 2006;58(3):651-6.
71. Davey P, Brown E, Fenelon L, et al. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev 2005;(4):CD003543.
72. Polk RE, Hohmann SF, Medvedev S, Ibrahim O. Benchmarking risk-adjusted adult antibacterial drug use in 70 US academic medical center hospitals. Clin Infect Dis 2011;53 (11):1100-10.
73. CDC. Why Inpatient Stewardship? - Get Smart for Healthcare, 2010. Available from http://www.cdc.gov/getsmart/healthcare/ inpatient-stewardship. html. Accessed April 28, 2012.
74. Survey & Certification Focus on Patient Safety and Quality. Draft Surveyor Worksheets, 2011. Available from https://http://www. cms.gov/Medicare/Provider-Enrollment-and-Certification/Survey CertificationGenInfo/downloads//SCLetter12-01.pdf. Accessed April 28, 2012.
75. Morris AM, Brener S, Dresser L, et al. Use of a structured panel process to define quality metrics for antimicrobial stewardship programs. Infect Control Hosp Epidemiol 2012;33 (5):500-6.